Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prostaglandin-associated periorbitopathy in glaucoma patients receiving prostaglandin analogs
ChiCTR2100045465Phase 4Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Nov 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of bimatoprost, travoprost, latanoprost and tafluprost in open-angle glaucoma (OAG) and ocular hypertension (4 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: pupil distance, degree of exophthalmus and 1 more. Started Nov 2019; status: recruiting.
02
Drugs
bimatoprosttravoprostlatanoprosttafluprost
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on ChiCTR2100045465.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100045465.